Cargando…
Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potential
Protein kinase C isoform θ (PKCθ) is a key modulator of TCR signaling and mediates activation of NF-κB, NF-AT, and AP-1 transcription factors. Although in vitro studies of PKCθ(-/-) T cells have shown impaired activation responses, in vivo studies indicate that PKCθ requirement is not universal. Whi...
Autores principales: | Bronk, Crystina C., Yu, Xue-Zhong, Beg, Amer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418525/ https://www.ncbi.nlm.nih.gov/pubmed/22912640 http://dx.doi.org/10.3389/fimmu.2012.00259 |
Ejemplares similares
-
Intervention of PKC-θ as an immunosuppressive regimen
por: Sun, Zuoming
Publicado: (2012) -
Regulating the Regulator: Phosphorylation of PKC θ in T Cells
por: Freeley, Michael, et al.
Publicado: (2012) -
Alloreactivity of Virus-Specific T Cells: Possible Implication of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effects
por: Fuji, Shigeo, et al.
Publicado: (2013) -
Protein Kinase C-θ (PKC-θ) in Natural Killer Cell Function and Anti-Tumor Immunity
por: Anel, Alberto, et al.
Publicado: (2012) -
Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015)